Bio-Rad Laboratories (BIO-B) EBIT Margin Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -812.00 |
| Dec 31, 2025 | -4,065.00 |
| Sep 30, 2025 | -693.00 |
| Jun 30, 2025 | 220.00 |
| Mar 31, 2025 | -896.00 |
| Dec 31, 2024 | -75.00 |
| Sep 30, 2024 | -32.00 |
| Jun 30, 2024 | 605.00 |
| Mar 31, 2024 | -292.00 |
| Dec 31, 2023 | 5,080.00 |
| Sep 30, 2023 | 773.00 |
| Jun 30, 2023 | 555.00 |
| Mar 31, 2023 | 123.00 |
| Dec 31, 2022 | 886.00 |
| Sep 30, 2022 | 664.00 |
| Jun 30, 2022 | 1,812.00 |
| Mar 31, 2022 | 1,567.00 |
| Dec 31, 2021 | 2,102.00 |
| Sep 30, 2021 | 1,653.00 |
| Jun 30, 2021 | 1,222.00 |
| Mar 31, 2021 | 959.00 |
| Dec 31, 2020 | 1,307.00 |
| Sep 30, 2020 | 998.00 |
| Jun 30, 2020 | 169.00 |
| Mar 31, 2020 | 575.00 |
| Dec 31, 2019 | 102.00 |
| Sep 30, 2019 | 399.00 |
| Jun 30, 2019 | 134.00 |
| Mar 31, 2019 | 620.00 |
| Dec 31, 2018 | -4,549.00 |
| Sep 30, 2018 | 90.00 |
| Jun 30, 2018 | -247.00 |
| Mar 31, 2018 | 88.00 |
| Sep 30, 2017 | -595.00 |
| Jun 30, 2017 | -1,470.00 |
| Mar 31, 2017 | -594.00 |
| Dec 31, 2016 | -2,239.00 |
| Sep 30, 2016 | -985.00 |
| Jun 30, 2016 | -786.00 |
| Mar 31, 2016 | -955.00 |
| Dec 31, 2015 | -415.00 |
| Sep 30, 2015 | -891.00 |
| Jun 30, 2015 | -663.00 |
| Mar 31, 2015 | -666.00 |
| Dec 31, 2014 | -291.00 |
| Sep 30, 2014 | -835.00 |
| Jun 30, 2014 | -457.00 |